# FDA Inspection 1179611 - Adam Gerstenblith, M.D. - September 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/adam-gerstenblith-md/b1fb5f11-6ad0-44fe-a481-e0c7478ed0ca
Source feed: FDA_Inspections

> FDA Inspection 1179611 for Adam Gerstenblith, M.D. on September 02, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1179611
- Company Name: Adam Gerstenblith, M.D.
- Inspection Date: 2022-09-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/adam-gerstenblith-md/08640441-6f1c-47f0-978e-08d083ca5fd8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c